---
title: "Edesa Biotech to raise $15 million to fund trial; shares rise"
date: "2025-02-13 23:08:35"
summary: "** Shares of drug developer Edesa Biotech surge 68.9% to $3.1 in morning trade ** EDSA says it is raising $15 million from private placement of shares** Co says it will use the proceeds towards a mid-stage trial evaluating its experimental treatment EB06 in patients with nonsegmental vitiligo, a chronic..."
categories:
  - "Reuters"
lang:
  - "en"
translations:
  - "en"
tags:
  - "Reuters"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

\*\* Shares of drug developer Edesa Biotech surge 68.9% to $3.1 in morning trade

\*\* EDSA says it is raising $15 million from private placement of shares

\*\* Co says it will use the proceeds towards a mid-stage trial evaluating its experimental treatment EB06 in patients with nonsegmental vitiligo, a chronic skin disorder that causes patches and loss of skin color

\*\* Co says shares were offered directly to the investors without a placement agent, underwriter, broker or dealer

\*\* Co has 3.47 mln outstanding shares and market value of $6.45 mln - LSEG data

\*\* Stock fell ~69% in the last 12 months

[Reuters](https://www.tradingview.com/news/reuters.com,2025:newsml_L4N3P41J5:0-edesa-biotech-to-raise-15-million-to-fund-trial-shares-rise/)
